Search research articles
Contact Us
Filters
Showing results (271-280 of 329) with videos related to
Page
of 33
Sort By:
The Lancet. Diabetes & Endocrinology
|
February 29, 2024
5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study
Michael Ej Lean, Wilma S Leslie, Alison C Barnes, et al.
BMJ Open Diabetes Research & Care
|
August 6, 2021
Ethnic differences in prevalence of actionable HbA1c levels in UK Biobank: implications for screening
Jana J Anderson, Paul Welsh, Frederick K Ho, et al.
Journal of Alzheimer'S Disease : JAD
|
July 12, 2020
Alzheimer's Disease Susceptibility Gene Apolipoprotein E (APOE) and Blood Biomarkers in UK Biobank (N = 395,769)
Amy C Ferguson, Rachana Tank, Laura M Lyall, et al.
Cardiovascular Research
|
October 14, 2020
High sodium intake, glomerular hyperfiltration, and protein catabolism in patients with essential hypertension
Giacomo Rossitto, Giuseppe Maiolino, Silvia Lerco, et al.
European Journal of Heart Failure
|
September 30, 2017
Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED-HF study
Paul Welsh, Lei Kou, Changhong Yu, et al.
Plos Medicine
|
June 26, 2009
Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events?
Naveed Sattar, Heather M Murray, Paul Welsh, et al.
BMC Medicine
|
November 10, 2020
Comparison of two different frailty measurements and risk of hospitalisation or death from COVID-19: findings from UK Biobank
Fanny Petermann-Rocha, Peter Hanlon, Stuart R Gray, et al.
Plos Medicine
|
November 26, 2024
Routine measurement of cardiometabolic disease risk factors in primary care in England before, during, and after the COVID-19 pandemic: A population-based cohort study
Frederick K Ho, Caroline Dale, Mehrdad A Mizani, et al.
JAMA
|
August 23, 2012
Lipid-modifying therapies and risk of pancreatitis: a meta-analysis
David Preiss, Matti J Tikkanen, Paul Welsh, et al.
JAMA Cardiology
|
June 4, 2025
Cellular Adhesion Molecules and Adverse Outcomes in Chronic Heart Failure: Findings From the DAPA-HF Randomized Clinical Trial
Kirsty McDowell, Paul Welsh, Kieran F Docherty, et al.
Page
of 33
Search research articles
Search
Showing results (271-280 of 329) with videos related to
Sort By:
Page
of 33
The Lancet. Diabetes & Endocrinology
|
February 29, 2024
5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study
Michael Ej Lean, Wilma S Leslie, Alison C Barnes, et al.
BMJ Open Diabetes Research & Care
|
August 6, 2021
Ethnic differences in prevalence of actionable HbA1c levels in UK Biobank: implications for screening
Jana J Anderson, Paul Welsh, Frederick K Ho, et al.
Journal of Alzheimer'S Disease : JAD
|
July 12, 2020
Alzheimer's Disease Susceptibility Gene Apolipoprotein E (APOE) and Blood Biomarkers in UK Biobank (N = 395,769)
Amy C Ferguson, Rachana Tank, Laura M Lyall, et al.
Cardiovascular Research
|
October 14, 2020
High sodium intake, glomerular hyperfiltration, and protein catabolism in patients with essential hypertension
Giacomo Rossitto, Giuseppe Maiolino, Silvia Lerco, et al.
European Journal of Heart Failure
|
September 30, 2017
Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED-HF study
Paul Welsh, Lei Kou, Changhong Yu, et al.
Plos Medicine
|
June 26, 2009
Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events?
Naveed Sattar, Heather M Murray, Paul Welsh, et al.
BMC Medicine
|
November 10, 2020
Comparison of two different frailty measurements and risk of hospitalisation or death from COVID-19: findings from UK Biobank
Fanny Petermann-Rocha, Peter Hanlon, Stuart R Gray, et al.
Plos Medicine
|
November 26, 2024
Routine measurement of cardiometabolic disease risk factors in primary care in England before, during, and after the COVID-19 pandemic: A population-based cohort study
Frederick K Ho, Caroline Dale, Mehrdad A Mizani, et al.
JAMA
|
August 23, 2012
Lipid-modifying therapies and risk of pancreatitis: a meta-analysis
David Preiss, Matti J Tikkanen, Paul Welsh, et al.
JAMA Cardiology
|
June 4, 2025
Cellular Adhesion Molecules and Adverse Outcomes in Chronic Heart Failure: Findings From the DAPA-HF Randomized Clinical Trial
Kirsty McDowell, Paul Welsh, Kieran F Docherty, et al.
Page
of 33